ArticleJTCVS techniques2026
Establishment of a feasible surgical strategy for aortoesophageal fistula.
Article in JTCVS techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Aortoesophageal fistula (AEF) represents one of the most challenging and devastating complications in aortic surgery. This study aimed to evaluate the feasibility, technical considerations, and clinical outcomes of our standardized multidisciplinary strategy for AEF, which has been consistently applied since 2008. Methods: This retrospective study included 21 patients with AEF who underwent open surgery from January 2008 to September 2025. The primary end point was freedom from infection-related death, reflecting the central role of infection control in AEF management. Secondary end points included hospital mortality, overall survival, and the esophageal reconstruction rate. Results: The mean age was 69.3 ± 11.2 years. Hospital mortality after open surgery was 26.9%. The 10-year overall survival and freedom from infection-related death were 38.4 ± 13.2% and 89.7 ± 6.8%, respectively. After implementation of our current standardized strategy in 2008, no recurrent infections were observed, and 10 patients successfully completed reconstruction. Conclusions: Although hospital mortality remains substantial, long-term outcomes were favorable. The current multidisciplinary surgical strategy was associated with improved infection-related outcomes, with no recurrent infections observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.